Literature DB >> 219217

Morphological and biochemical characterization of viral particles produced by the tsO45 mutant of vesicular stomatitis virus at restrictive temperature.

T J Schnitzer, C Dickson, R A Weiss.   

Abstract

The growth at restrictive temperature of tsO45, a group V (glycoprotein) conditional lethal mutant of vesicular stomatitis virus (VSV), was demonstrated to result in the production of large numbers of noninfectious viral particles. The infectivity of these tsO45 particles could be enhanced by procedures known to promote membrane fusion. Morphologically and biochemically these particles differed from wild-type VSV by their lack of viral glycoprotein. The other structural proteins of VSV were present and indistinguishable by size and relative proportion from those of virus grown at the permissive temperature. Examination of glycoprotein maturation at the restrictive temperature (39.5 degrees C) in tsO45-infected cells demonstrated the synthesis of normal viral glycoprotein but failed to demonstrate the presence of this glycoprotein in either the cell membrane or the envelope of free virions. The further absence of soluble viral glycoprotein from the supernatants of such cells strongly suggests that viral glycoprotein may not be necessary for the successful budding of VSV.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 219217      PMCID: PMC353098     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  39 in total

1.  Maturation of viral proteins in cells infected with temperature-sensitive mutants of vesicular stomatitis virus.

Authors:  D M Knipe; D Baltimore; H F Lodish
Journal:  J Virol       Date:  1977-03       Impact factor: 5.103

2.  Synthesis and distribution of vesicular stomatitis virus-specific polypeptides in the absence of progeny production.

Authors:  S P Little; A S Huang
Journal:  Virology       Date:  1977-08       Impact factor: 3.616

3.  Pseudotypes of vesicular stomatitis virus with envelope antigens provided by murine mammary tumor virus.

Authors:  J Závada; C Dickson; R Weiss
Journal:  Virology       Date:  1977-10-01       Impact factor: 3.616

4.  Analysis of the defects of temperature-sensitive mutants of vesicular stomatitis virus: intracellular degradation of specific viral proteins.

Authors:  D Knipe; H F Lodish; D Baltimore
Journal:  J Virol       Date:  1977-03       Impact factor: 5.103

5.  Proteins of helper-dependent RSV.

Authors:  C M Scheele; H Hanafusa
Journal:  Virology       Date:  1971-08       Impact factor: 3.616

6.  Temperature-sensitive mutants of vesicular stomatitis virus: synthesis of virus-specific proteins.

Authors:  P Printz; R R Wagner
Journal:  J Virol       Date:  1971-05       Impact factor: 5.103

7.  Pseudotypes of vesicular stomatitis virus with the envelope properties of mammalian and primate retroviruses.

Authors:  T J Schnitzer; R A Weiss; J Zavada
Journal:  J Virol       Date:  1977-09       Impact factor: 5.103

8.  Mechanism of formation of pseudotypes between vesicular stomatitis virus and murine leukemia virus.

Authors:  O N Witte; D Baltimore
Journal:  Cell       Date:  1977-07       Impact factor: 41.582

9.  Proteins of vesicular stomatitis virus and of phenotypically mixed vesicular stomatitis virus-simian virus 5 virions.

Authors:  J J McSharry; R W Compans; P W Choppin
Journal:  J Virol       Date:  1971-11       Impact factor: 5.103

10.  Tunicamycin inhibits glycosylation and multiplication of Sindbis and vesicular stomatitis viruses.

Authors:  R Leavitt; S Schlesinger; S Kornfeld
Journal:  J Virol       Date:  1977-01       Impact factor: 5.103

View more
  34 in total

1.  The m protein of vesicular stomatitis virus: variability in lipid-protein interaction compatible with function.

Authors:  J Lenard; D A Mancarella; T Wilson; J A Reidler; P M Keller; E L Elson
Journal:  Biophys J       Date:  1982-01       Impact factor: 4.033

Review 2.  Virus maturation by budding.

Authors:  H Garoff; R Hewson; D J Opstelten
Journal:  Microbiol Mol Biol Rev       Date:  1998-12       Impact factor: 11.056

3.  Functional role of hepatitis C virus chimeric glycoproteins in the infectivity of pseudotyped virus.

Authors:  L M Lagging; K Meyer; R J Owens; R Ray
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

4.  Recovery of a fully viable chimeric human parainfluenza virus (PIV) type 3 in which the hemagglutinin-neuraminidase and fusion glycoproteins have been replaced by those of PIV type 1.

Authors:  T Tao; A P Durbin; S S Whitehead; F Davoodi; P L Collins; B R Murphy
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

5.  Stereo images of vesicular stomatitis virus assembly.

Authors:  W F Odenwald; H Arnheiter; M Dubois-Dalcq; R A Lazzarini
Journal:  J Virol       Date:  1986-03       Impact factor: 5.103

6.  Further characterization of the vesicular stomatitis virus temperature-sensitive O45 mutant: intracellular conversion of the glycoprotein to a soluble form.

Authors:  S S Chen; A S Huang
Journal:  J Virol       Date:  1986-08       Impact factor: 5.103

7.  Phenotypic revertants of temperature-sensitive M protein mutants of vesicular stomatitis virus: sequence analysis and functional characterization.

Authors:  K Morita; R Vanderoef; J Lenard
Journal:  J Virol       Date:  1987-02       Impact factor: 5.103

8.  Role of heterologous and homologous glycoproteins in phenotypic mixing between Sendai virus and vesicular stomatitis virus.

Authors:  K Metsikkö; H Garoff
Journal:  J Virol       Date:  1989-12       Impact factor: 5.103

9.  Purified matrix protein of vesicular stomatitis virus blocks viral transcription in vitro.

Authors:  B P De; G B Thornton; D Luk; A K Banerjee
Journal:  Proc Natl Acad Sci U S A       Date:  1982-12       Impact factor: 11.205

10.  Characterization of the soluble glycoprotein released from vesicular stomatitis virus-infected cells.

Authors:  P A Chatis; T G Morrison
Journal:  J Virol       Date:  1983-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.